Rosebraugh named director of Office of Drug Evaluation II.

Curtis (Curt) Rosebraugh, M.D., has been appointed as the new Director of the Office of Drug Evaluation II, FDA announced May 12.

Rosebraugh received a B.S. degree in pharmacy and his M.D. degree from the University of Kansas. Following medical school he completed an internship and residency in internal medicine, also at the University of Kansas. Rosebraugh also completed a fellowship in clinical pharmacology at Georgetown University and received a Masters of Public Health degree from Johns Hopkins University.

Prior to joining FDA, Rosebraugh was an Assistant Professor of Internal Medicine at the University of Kansas-Wichita and later an Assistant Professor of Internal Medicine and Internal Medicine Clerkship Director at the University of Texas Medical Branch-Galveston. In 2000, Rosebraugh joined FDA as a medical officer in the Division of Pulmonary and Allergy Drugs Products. From 2003-2005, he served as the Deputy Director of the Office of Nonprescription Products and was Acting Director of the Division of Nonprescription Clinical Evaluation in that Office. In 2005 he became Deputy Director of the Office of Drug Evaluation II and became Acting Director in September, 2007.